Effects of flu vaccination during pregnancy on mothers and infants in rural Nepal
Associations between influenza vaccination during pregnancy and outcomes related to maternal influenza disease, infant anthropometry, and cost-effectiveness in rural Nepal
This study looks at how getting the flu shot while pregnant can help keep moms healthy and support their babies' growth in rural Nepal, with the hope of improving vaccination practices for better health outcomes for families.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11098410 on NIH RePORTER |
What this research studies
This research investigates how influenza vaccination during pregnancy affects maternal health and infant growth outcomes in rural Nepal. It aims to gather data on the disease burden of influenza among pregnant individuals and their infants, focusing on the timing of vaccination and its cost-effectiveness. By analyzing data from a previous study, the project seeks to inform vaccine policy and improve maternal immunization practices in low- and middle-income countries. The ultimate goal is to enhance health outcomes for mothers and their babies through effective vaccination strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant individuals living in rural Nepal, particularly those in their second or third trimester.
Not a fit: Patients who are not pregnant or those living outside of rural Nepal may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for pregnant individuals and their infants by optimizing influenza vaccination practices.
How similar studies have performed: Previous research has shown that maternal vaccination can significantly reduce influenza-related morbidity and mortality, indicating a promising approach for this study.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Frivold, Collrane — University of Washington
- Study coordinator: Frivold, Collrane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.